MedPath

Study of the Effect of the combination of exosomes extracted from follicular flouid,PRP & gonadotropns into the ovaries of POF & POI Patients.

Phase 2
Recruiting
Conditions
Premature Ovarian failure(POF) / Premature Ovarian Insufficiency (POI).
Female infertility associated with anovulation
N97.0
Registration Number
IRCT20230528058312N1
Lead Sponsor
Tahoora,Specialized Infertility treatment And limited surgery Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
24
Inclusion Criteria

Women with premature menopause POF
Women with premature ovarian failure POI
Normal women with Grade A eggs

Exclusion Criteria

Women with idiopathic infertility
Women with adequate ovarian reserve

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Absence of eggs in the ovaries of women under 40 years and primary or secondary amenorrhea for more than 4 months in women under 40 years with an elevated serum level of Follicular Stimulated Hormone(higher than 25 mIU/mL. Timepoint: 15 days after the injection and then every month at the time of ovulation during one year. Method of measurement: Transvaginal ultrasound device, Hormonal Test by Elisa Kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath